Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Instituto Alexander Fleming (Site 1008)

Buenos Aires, Buenos Aires F.D. C1426ANZ, ArgentinaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Lung cancer

Running trials

Active, not recruiting
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
NCT05722015· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error

Under construction, not live – Instituto Alexander Fleming (Site 1008): trial site – Frontlight Research